Cargando…

KMT2C mutation is a diagnostic molecular marker for primary thyroid osteosarcoma: A case report and literature review

Primary thyroid osteosarcoma is an extremely rare tumor which is associated with a poor prognosis. In this study, we describe an additional case. A 4.5 × 3.8 cm irregular heterogeneous nodule was examined in the left thyroid gland of a 72-year-old woman. Cytological smears and histopathological spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xinpei, Wang, Qianqian, Su, Peng, Chen, Chunyan, Han, Bo, Liu, Zhiyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679279/
https://www.ncbi.nlm.nih.gov/pubmed/36425109
http://dx.doi.org/10.3389/fmed.2022.1030888
_version_ 1784834156650299392
author Wang, Xinpei
Wang, Qianqian
Su, Peng
Chen, Chunyan
Han, Bo
Liu, Zhiyan
author_facet Wang, Xinpei
Wang, Qianqian
Su, Peng
Chen, Chunyan
Han, Bo
Liu, Zhiyan
author_sort Wang, Xinpei
collection PubMed
description Primary thyroid osteosarcoma is an extremely rare tumor which is associated with a poor prognosis. In this study, we describe an additional case. A 4.5 × 3.8 cm irregular heterogeneous nodule was examined in the left thyroid gland of a 72-year-old woman. Cytological smears and histopathological specimens showed typical features of osteosarcoma with a neoplastic lesion rich in spindle cells with occasional multinucleated cells and lace-like osteoid matrix. Negative immunoreaction with epithelial markers and positive immunoreaction with SATB2 and low Ki-67 labeling index suggested the diagnosis of osteosarcoma. Multiple KMT2C gene mutations determined by next-generation sequencing further confirmed the diagnosis.
format Online
Article
Text
id pubmed-9679279
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96792792022-11-23 KMT2C mutation is a diagnostic molecular marker for primary thyroid osteosarcoma: A case report and literature review Wang, Xinpei Wang, Qianqian Su, Peng Chen, Chunyan Han, Bo Liu, Zhiyan Front Med (Lausanne) Medicine Primary thyroid osteosarcoma is an extremely rare tumor which is associated with a poor prognosis. In this study, we describe an additional case. A 4.5 × 3.8 cm irregular heterogeneous nodule was examined in the left thyroid gland of a 72-year-old woman. Cytological smears and histopathological specimens showed typical features of osteosarcoma with a neoplastic lesion rich in spindle cells with occasional multinucleated cells and lace-like osteoid matrix. Negative immunoreaction with epithelial markers and positive immunoreaction with SATB2 and low Ki-67 labeling index suggested the diagnosis of osteosarcoma. Multiple KMT2C gene mutations determined by next-generation sequencing further confirmed the diagnosis. Frontiers Media S.A. 2022-11-08 /pmc/articles/PMC9679279/ /pubmed/36425109 http://dx.doi.org/10.3389/fmed.2022.1030888 Text en Copyright © 2022 Wang, Wang, Su, Chen, Han and Liu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Wang, Xinpei
Wang, Qianqian
Su, Peng
Chen, Chunyan
Han, Bo
Liu, Zhiyan
KMT2C mutation is a diagnostic molecular marker for primary thyroid osteosarcoma: A case report and literature review
title KMT2C mutation is a diagnostic molecular marker for primary thyroid osteosarcoma: A case report and literature review
title_full KMT2C mutation is a diagnostic molecular marker for primary thyroid osteosarcoma: A case report and literature review
title_fullStr KMT2C mutation is a diagnostic molecular marker for primary thyroid osteosarcoma: A case report and literature review
title_full_unstemmed KMT2C mutation is a diagnostic molecular marker for primary thyroid osteosarcoma: A case report and literature review
title_short KMT2C mutation is a diagnostic molecular marker for primary thyroid osteosarcoma: A case report and literature review
title_sort kmt2c mutation is a diagnostic molecular marker for primary thyroid osteosarcoma: a case report and literature review
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679279/
https://www.ncbi.nlm.nih.gov/pubmed/36425109
http://dx.doi.org/10.3389/fmed.2022.1030888
work_keys_str_mv AT wangxinpei kmt2cmutationisadiagnosticmolecularmarkerforprimarythyroidosteosarcomaacasereportandliteraturereview
AT wangqianqian kmt2cmutationisadiagnosticmolecularmarkerforprimarythyroidosteosarcomaacasereportandliteraturereview
AT supeng kmt2cmutationisadiagnosticmolecularmarkerforprimarythyroidosteosarcomaacasereportandliteraturereview
AT chenchunyan kmt2cmutationisadiagnosticmolecularmarkerforprimarythyroidosteosarcomaacasereportandliteraturereview
AT hanbo kmt2cmutationisadiagnosticmolecularmarkerforprimarythyroidosteosarcomaacasereportandliteraturereview
AT liuzhiyan kmt2cmutationisadiagnosticmolecularmarkerforprimarythyroidosteosarcomaacasereportandliteraturereview